(3-065) Outpatient Pharmacy Management of Dispensing Extended-Release Injectable Buprenorphine for Opioid Use Disorder at a Federally Qualified Health Center
Monday, December 5, 2022
12:00 PM – 1:00 PM
Location: Bayside A, Level 1
Category: Descriptive Report Topic: Ambulatory Care
Co-Author(s): Laura Ayento, Stephen Gutekanst
Primary Author(s)
Megan T. Murtagh
Student Pharmacist University of Illinois Chicago College of Pharmacy, Illinois
